Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Synergic Effect of Botulinum Toxin Type-A and Triamcinolone Alleviates Scar Pruritus By Modulating Epidermal Hyperinnervation: A Preliminary Report.

< BACK TO ARCHIVE


2021 Feb 28


Aesthet Surg J


http://www.ncbi.nlm.nih.gov/pubmed/33662123?dopt=Abstract

Synergic Effect of Botulinum Toxin Type-A and Triamcinolone Alleviates Scar Pruritus By Modulating Epidermal Hyperinnervation: A Preliminary Report.

Authors

Synergic Effect of Botulinum Toxin Type-A and Triamcinolone Alleviates Scar Pruritus By Modulating Epidermal Hyperinnervation: A Preliminary Report.
Huang S-H, Wu K-W, Lo J-J, Wu S-H
Aesthet Surg J. 2021 Feb 28.
PMID: 33662123.

Abstract

Patients often experience scar-related pruritus, which negatively affects quality of life. Triamcinolone acetonide (TAC) is widely used to treat pathological scars, and botulinum toxin type-A (BTX-A) reportedly improves scarring and associated discomfort.
Read This Paper